Sepsis Alliance

ExThera Medical Taps Current Board Member and Top Finance Executive to Take the Helm

Retrieved on: 
Wednesday, November 29, 2023
Biotechnology, Oncology, General Health, Health, COVID-19, Medical Devices, Infectious Diseases, Other Health, Jim Crockett, UBS, Bank, Cystic fibrosis, J. P. Morgan, National Council, Sepsis, Morgan Stanley, Medtech, Sepsis Alliance, Research, NASD, Adviser, University, Infection, First Republic, Family, Knowledge, Wells Fargo, RBC, Cryptocurrency

ExThera Medical Corporation is pleased to announce Erin Borger has assumed the role of CEO of ExThera.

Key Points: 
  • ExThera Medical Corporation is pleased to announce Erin Borger has assumed the role of CEO of ExThera.
  • Robert Ward, Chairman, President, and Founder will continue in those roles while focusing on Research, Product Development/IP and Manufacturing Scale Up.
  • Erin most recently held the role of Managing Director and Director of Strategic Growth at UBS Financial Services Inc .
  • He recently sat on the Board of Directors for the stem cell company Longeveron (NASD: LGVN) and is currently a Board Member of the Sepsis Alliance, the Applebaum Foundation, and ExThera Medical.

Sepsis Alliance Reinforces Call for National Sepsis Action Plan as Awareness of the Term Sepsis Dips to 63%

Retrieved on: 
Wednesday, September 13, 2023
Infection, Education, Sepsis, YouGov, Sepsis Alliance, Survival, Woman, Temperature, Septic shock, Incidence, Patient, SAN, Smoke, Clutch (eggs), Knowledge, Diagnosis, Government, Ageing, Smoking, Social media, Birth control, Pharmaceutical industry, Black, Hispanic

SAN DIEGO, Sept. 13, 2023 /PRNewswire-PRWeb/ -- Sepsis Alliance's annual awareness survey found that 63% of U.S. adults are aware of the term "sepsis," down from 66% in 2022. Of those aware of the term sepsis, only 15% were able to identify the four most common symptoms that would lead one to seek emergency care for sepsis, down from 19% in 2022. Due to these stalling numbers, coupled with the mounting economic and human cost of sepsis, Sepsis Alliance is calling for a National Sepsis Action Plan with the potential to raise sepsis awareness and save lives.

Key Points: 
  • Due to these stalling numbers, coupled with the mounting economic and human cost of sepsis, Sepsis Alliance is calling for a National Sepsis Action Plan with the potential to raise sepsis awareness and save lives.
  • A National Sepsis Action Plan has the potential to save thousands of lives from sepsis each year.
  • In 2003, the first sepsis awareness survey found 19% of U.S. adults were aware of the term sepsis.
  • You can learn more about sepsis, Sepsis Alliance, and how to raise further awareness at Sepsis.org.

Sepsis Alliance Calls on Biden-Harris Administration for a National Sepsis Action Plan

Retrieved on: 
Monday, September 11, 2023
Infection, Innovation Act, Education, Sepsis, Sepsis Alliance, Cancer, Congress, Death, Hospital, MD, SAN, World Health Organization, United Kingdom, Diagnosis, Government, Moral and National Education controversy, Pelvic floor dysfunction, Health care, Management, Pharmaceutical industry, Medical device, Outcome

SAN DIEGO, Sept. 11, 2023 /PRNewswire-PRWeb/ -- Sepsis Alliance, an education and advocacy organization dedicated to saving lives from sepsis across the U.S., is calling on the Biden-Harris Administration to develop and implement a National Sepsis Action Plan for addressing and eliminating the national burden of sepsis. The World Health Organization and the G7 have called for international action aimed at reducing the human and economic burdens of this devastating condition. Some nations, including Switzerland and the United Kingdom, have implemented national sepsis strategies, but the United States has yet to do so. A National Sepsis Action Plan is urgently needed to guide work aimed at countering sepsis, saving lives, and reducing healthcare costs.

Key Points: 
  • SAN DIEGO, Sept. 11, 2023 /PRNewswire-PRWeb/ -- Sepsis Alliance, an education and advocacy organization dedicated to saving lives from sepsis across the U.S., is calling on the Biden-Harris Administration to develop and implement a National Sepsis Action Plan for addressing and eliminating the national burden of sepsis.
  • A National Sepsis Action Plan is urgently needed to guide work aimed at countering sepsis, saving lives, and reducing healthcare costs.
  • A National Sepsis Action Plan in the United States would work to bring together relevant government agencies and stakeholders, organize a national response to sepsis, and help improve sepsis diagnosis and treatment.
  • Sepsis Alliance urges the Biden-Harris Administration to develop and implement a National Sepsis Action Plan, catalyzing efforts to solve this deadly and costly condition.

In Recognition of Sepsis Awareness Month, Magnolia Medical Intensifies Efforts to Combat the Clinical and Economic Risks of Sepsis Misdiagnosis

Retrieved on: 
Thursday, September 7, 2023
Magnolia, University, Education, Sepsis, Sepsis Alliance, Public, Attention, AMR, Approximation error, Hospital, AVP, Patient, Patient safety, Risk, Invention, World Health Organization, Entrepreneurship, Mortality, Blood culture, Health, Death, Bloodstream infections, Pharmaceutical industry, Nursing

SEATTLE, Sept. 7, 2023 /PRNewswire/ -- Magnolia Medical Technologies, Inc., the inventors of the Steripath® Initial Specimen Diversion Device® (ISDD®) and the ISDD market, is intensifying efforts to combat sepsis misdiagnosis this Sepsis Awareness Month. In recognition of the far-reaching implications of an inaccurate sepsis test result, including the risk of accelerating antimicrobial resistance (AMR), the company is committed to raising awareness through peer-reviewed scientific data and programmatic education.

Key Points: 
  • "Sepsis is not just a medical emergency; it's a societal crisis that exacts a terrible toll on patients and the healthcare system, alike.
  • Sepsis Awareness Month is of particular significance to Magnolia Medical.
  • This is a critical issue that requires immediate attention," said Tammy Johnson, AVP, Clinical Strategy at Magnolia Medical.
  • Magnolia Medical is sponsoring a webinar at the 2023 Sepsis Alliance Summit , titled "State of Sepsis Awareness 2023," on September 28th.

Todos Medical Enters Into Letter of Intent for Provista Diagnostics to License PCR-based Sepsis Diagnostic Test AcuSept LDT Rights From Acumen Diagnostics

Retrieved on: 
Tuesday, March 28, 2023
Acumen, Infection, US Foods, LDT, Sepsis Alliance, Vizient, Inc., COVID-19, OTCQB, Biomarker, Septic shock, Sepsis, Hospital, Patient, Physician, Risk, Laboratory developed test, Diagnosis, United, Letter, Death, PCR, Medical device, Pharmaceutical industry

AcuSept is a host (patient) immune response test that identifies 19 mRNA biomarkers of infection, sepsis and septic shock, and can be used to monitor patient response to treatment.

Key Points: 
  • AcuSept is a host (patient) immune response test that identifies 19 mRNA biomarkers of infection, sepsis and septic shock, and can be used to monitor patient response to treatment.
  • Under the terms of the agreement, Provista will also conduct clinical validation studies on AcuSept® to generate the data in the United States to support Acumen Diagnostics’ 510(k) submission to the US Food & Drug Administration.
  • Hospitalized COVID-19 patients are 300% more likely to develop septic shock as compared with hospitalized influenza patients.
  • “Sepsis presents a huge human and economic toll on the healthcare system as the #1 cause of death in hospitals,” said Gerald Commissiong, President & CEO of Todos Medical.

FDA Clears Cytovale’s® IntelliSep® Sepsis Test, First in a New Class of Emergency Department-Focused Diagnostic Tools

Retrieved on: 
Wednesday, January 18, 2023
Pharmaceutical, Finance, Medical Devices, Infectious Diseases, Hospitals, Data Management, Professional Services, Technology, Practice Management, Nursing, Clinical Trials, Managed Care, Medical Supplies, General Health, FDA, Biotechnology, Health, Health Technology, Cell, Our Lady of the Lake Regional Medical Center, Hospital, Prostate cancer, Infection, Critical care, LSU Health Sciences Center New Orleans, Heart, Septic, Pressure, CMS, Death, Centers for Medicare & Medicaid Services, Manifest and latent functions and dysfunctions, MD, Risk, Band, Food and Drug Administration, Research, United, Sepsis Alliance, Medicare, Band I, Sepsis, Food, Diagnosis, Patient, Band 3 anion transport protein, Breast cancer, Probability, Joe Byrd (Cherokee Nation Principal Chief), Medical device, Medical imaging

IntelliSep is a groundbreaking diagnostic tool that helps clinicians recognize sepsis and supports critical time-sensitive clinical decisions, providing test results in under 10 minutes.

Key Points: 
  • IntelliSep is a groundbreaking diagnostic tool that helps clinicians recognize sepsis and supports critical time-sensitive clinical decisions, providing test results in under 10 minutes.
  • The first in a new class of ED-focused diagnostic tools that assess host response, the test is a simple, fast, and intuitive solution that provides actionable answers directly from a standard blood draw.
  • IntelliSep categorizes patients into three bands according to their probability of sepsis, with Band 1 indicating low probability of sepsis and Band 3 indicating high probability of sepsis.
  • "Every minute is crucial in identifying sepsis, and IntelliSep has the potential to transform clinical approaches to sepsis triage and diagnosis and save countless lives."

Sepsis Alliance Survey Reveals Antimicrobial Resistance and Antibiotic Resistance Considered "Major Problem" to Healthcare Professionals

Retrieved on: 
Friday, November 18, 2022
ASP, SAN, Sepsis Alliance, World Health Organization, WHO, Candid (organization), Pharmacist, Knowledge, Infection, DO, Legislation, Survivor, Parasitism, ID, Medicine, Eye, Education, Bacteria, Fungus, Patient, Hospital-acquired infection, Sepsis, Physician, Risk, Virus, AMR, Pharmaceutical Research and Manufacturers of America, Public health, Pharmaceutical industry, Antibiotics, Vaccine

SAN DIEGO, Nov. 18, 2022 /PRNewswire-PRWeb/ -- Antimicrobial Resistance (AMR) is a World Health Organization (WHO) top-10 global public health threat facing humanity, yet only 52% of adults worldwide are aware of the term and fewer understand the potential effects of AMR. In September 2022, Sepsis Alliance heralded a survey conducted by Radius Global Market Research of more than 150 Infectious Disease (ID) Physicians and Pharmacists who have practiced medicine for at least one year to determine their knowledge of AMR, their institution's AMR education, and their views on what might help lessen the global burden of AMR. Keep reading to learn more about the findings of this first-of-its-kind survey.

Key Points: 
  • As more germs become resistant to antimicrobial medicines used to treat infection, more people are at risk for developing sepsis.
  • "Sepsis Alliance knows the value of patient education for improved recognition and outcomes," said Thomas Heymann , Sepsis Alliance President and CEO.
  • After over ten years of educational efforts for the general public and healthcare professionals through Sepsis.org , Sepsis Alliance Clinical Community , Sepsis Alliance Institute , and Sepsis Alliance Voices , awareness is at 66%.
  • Sepsis Alliance is the convener of Sepsis Innovation Collaborative , a multi-stakeholder public/private collaborative dedicated to innovations in sepsis diagnosis and management.

Sotera Announces Digital Patient Vital Sign Monitoring Solution for Early Sepsis

Retrieved on: 
Thursday, October 13, 2022
Sepsis, Visi, Hospital, ICU, Oxygen saturation (medicine), Infection, Diagnosis, Nursing, Critical care, Patient, Program, Blood pressure, MAP, Technology, Sepsis Alliance, Knowledge, Posture, Continuity, CEO, AFIB, Skin temperature, Fever, Heart rate, Vital signs, Pharmaceutical industry, Medical imaging, Medical device

Sotera has introduced ViSi Mobile, a solution that provides remote, real-time access to vital sign data for medical professionals. This includes the early signs and symptoms of sepsis, such as a rapid heartbeat, low blood pressure, fever, shortness of breath, and confusion.

Key Points: 
  • The Sepsis Alliance reports that sepsis is the leading cause of hospitalization expenses in the United States.
  • The yearly cost of acute sepsis hospitalization and skilled nursing care is estimated at $62 billion, and early monitoring and prevention can substantially reduce this cost.
  • Dr. Devin McCombie, the CEO of Sotera, states, "In today's busy healthcare industry, early identification of patient deterioration matters.
  • ViSi Mobile from Sotera aims to revolutionize critical care in US hospitals and care institutions with its improved suite of vital data sign monitoring and management capabilities.

Sepsis Alliance Seeks to Change the Sepsis Data Landscape: Lulu's Law Introduced in Congress

Retrieved on: 
Wednesday, September 21, 2022
Dance, Shock, Child, Incidence, Department, Trust, Risk, Sepsis, United States Department of Health and Human Services, Bicameralism, Legislation, Population, Survivor, Grief, Mikie Sherrill, HHS, Infection, Patient, Skiing, Cancer, CEO, Human services, Friends, Family, Diagnosis, Amputation, SAN, Hospital, Congress, Appendectomy, Innovation Act, Sepsis Alliance, Death, Haynes, Pharmaceutical industry, Research

SAN DIEGO, Sept. 21, 2022 /PRNewswire-PRWeb/ -- Ana Lucía "Lulu" Haynes was a healthy child from Montclair, New Jersey, who was known to her family and friends for her sweet, spunky, and bright personality. She attended preschool and loved activities such as dancing and skiing. In 2014, Lulu passed away suddenly from sepsis after an appendectomy. She was just four years old.

Key Points: 
  • Now, a bipartisan, bicameral bill focused on improving sepsis data collection has been introduced in Congress, and it's named in Lulu's honor.
  • The National Sepsis Data Trust, Research, Outcomes, and Innovation Act ( S.4827 / H.R.8865 ), or "Lulu's Law," would authorize the establishment of a national sepsis data trust within the Department of Health and Human Services (HHS) and would enable states to launch sepsis data pilot programs to eventually feed into the trust.
  • Lulu's Law will establish a national sepsis data trust to improve care and accelerate innovation to prevent, diagnose, and treat patients and support survivors.
  • "Better sepsis data collection will allow us to answer some of the most fundamental questions about this deadly condition.

Magnolia Medical Launches New Company Website to Educate Healthcare Providers on Blood Culture Contamination and to Increase Awareness of the Devastating Impact of Sepsis Misdiagnosis

Retrieved on: 
Thursday, June 2, 2022
Health, Blood culture, Goal, Intellectual property, Sepsis, Patent, CEO, Sepsis Alliance, Environment, Awareness, Pain, Solution, Multimedia, Magnolia, Nursing, FDA, Patient, Hospital, Technology, Compliance, ISDT, Antimicrobial stewardship, ZERO, Collection, Engineering, Mission, Invention, Patient safety, Medical device, Medicine, Pharmaceutical industry

SEATTLE, June 2, 2022 /PRNewswire/ -- Magnolia Medical Technologies, Inc., inventors of Steripath®, the only FDA 510(k)-cleared device platform specifically indicated to reduce blood culture contamination for sepsis testing accuracy,1 today announced the launch of its new website (www.magnolia-medical.com).

Key Points: 
  • For each person who signs the pledge to prevent sepsis misdiagnosis for better patient outcomes, Magnolia Medical will make a donation to Sepsis Alliance.
  • The website provides a streamlined user interface for improved navigation and has been designed to scale with Magnolia Medical's expanded educational offerings.
  • Magnolia Medical invented and patented the Initial Specimen Diversion Technique (ISDT) and Initial Specimen Diversion Device (ISDD) for blood culture collection and contamination prevention.
  • Indicated to reduce the frequency of blood culture contamination when contaminants are present, compared to standard method controls without diversion.